YARROW BIOSCIENCE, INC. Increase (Decrease) in Contract with Customer, Liability
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Contract with Customer, Liability of -$8.53 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2018-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2018-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2018-06-30 was -$8.08M.
- YARROW BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2018-03-31 was -$449.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for fiscal 2018 was -$8.53M.
- YARROW BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for fiscal 2017 was -$1.80M, a 117.39% decline from fiscal 2016.
- YARROW BIOSCIENCE, INC. increase (decrease) in contract with customer, liability for fiscal 2016 was $10.33M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | -$8.08M derived: sum of 3 quarters · filed 2020-03-03 | -$8.53M 10-K · filed 2020-03-03 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$8.08M derived: sum of 2 quarters · filed 2019-10-31 | -$8.53M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | -$8.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$8.53M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$449.00K 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | -$1.80M 10-K · filed 2020-03-03 | |||
| 2016-12-31 | $10.33M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |